Abstract 1443
Case Summary
Metastases in meningiomas are rare. Here is a case of a 60-year-old gentleman with 1-year history of right parietal swelling, treated as right parietal osteoma. However, symptoms worsen with increasing scalp swelling with headache and vomiting. MRI showed right parietal enplaque meningioma with calvarial involvement. 1st craniotomy, excision of tumor and titanium cranioplasty on January 2014. HPE reported as meningioma, WHO Grade 1. Surveillance MRI done showed stable lesion unlikely residual. Early 2017 he had the same symptom associated with right hemiparesis. MRI suggestive of tumour recurrence at surgical bed extending to left parasagittal parietal with involvement of adjacent left parietal bone, scalp, and superior sagittal sinus. 2nd craniotomy with tumor excision done on March 2017 with HPE reported as grade 1 meningioma. Subsequent MRI showed recurrence at right posterior parietal extra-axial bulk of tumor with mass effect. Proceed with 3rd operation, HPE reported as atypical meningioma, WHO grade II with bone invasion. Another MRI done showed new adjacent left high parietal meningioma. He was monitored and repeated MRI April 2018 tumor become larger. Clinically there are 2 lumps at previous surgical site associated with right upper limb focal seizure. During pre-operative investigation baseline chest x-ray showed large left lower lobe mass. CT Thorax in May 2018 reported confirm large lower lobe mass with another smaller lesion at left upper lobe. Lung biopsy done and consistent with metastatic meningioma. Planned for lobectomy and metastetectomy. However, upon reviewing him chest X-ray showed rapid progression of lung mass with poor performance status. Thus, he was offered best supportive care.
Editorial acknowledgement
Clinical trial identification
Resources from the same session
905 - Dose distribution in coronary arteries in left-sided breast cancer treated with Radiotherapy
Presenter: Umesh Velu
Session: Poster display - Cocktail
Resources:
Abstract
1060 - Metabolic Syndrome in Luminal-Type Non-Metastatic Breast Cancer during Hormonal Treatment Does it really have impact on prognosis?
Presenter: Kartika Taroeno-Hariadi
Session: Poster display - Cocktail
Resources:
Abstract
1148 - High Eosinophils Lymphocyte Ratio (ELR) Related With Subtype of Breast Cancer in Sanglah General Hospital, Bali
Presenter: Anak Agung Lestari
Session: Poster display - Cocktail
Resources:
Abstract
400 - Ribociclib (RIB) + endocrine therapy (ET) in Japanese women with hormone receptor-positive (HR+), HER2-negative (HER2–) advanced breast cancer (ABC)
Presenter: Norikazu Masuda
Session: Poster display - Cocktail
Resources:
Abstract
801 - Osteopontin Level and Promoter Polymorphism is Associated with Aggressiveness in Breast Cancer
Presenter: Mohamed Elbaiomy
Session: Poster display - Cocktail
Resources:
Abstract
1014 - Global Clinical Trials Validating Bioequivalence with China-Manufactured Trastuzumab Biosimilar, HLX02, and Herceptin®
Presenter: Quanying Zhang
Session: Poster display - Cocktail
Resources:
Abstract
1138 - Circular RNA NCAPG promotes breast cancer metastasis through acting as the sponge of miR-200s
Presenter: Yunjie He
Session: Poster display - Cocktail
Resources:
Abstract
145 - Repeat biopsy a must in recurrent breast cancer: A study from tertiary cancer centre in India.
Presenter: Abhishek Anand
Session: Poster display - Cocktail
Resources:
Abstract
804 - Meta-analysis of four Phase 3 RCTs of tamoxifen, versus 3rd generation aromatase inhibitors as 1st Line Endocrine Therapy for HR+ Advanced Breast Cancer
Presenter: John Robertson
Session: Poster display - Cocktail
Resources:
Abstract
1154 - Estimation of efficacy and safety of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in recurrent or metastatic breast cancer patients
Presenter: Sung Soo Kang
Session: Poster display - Cocktail
Resources:
Abstract